Introduction
============

Colorectal cancer (CRC), one of the most common cancers in developed countries, has a 5-year survival rate of about 60%.[@b1-copd-12-1233]--[@b3-copd-12-1233] Most patients are diagnosed at a relatively advanced age, when chronic comorbidities are often present. COPD is prevalent and commonly associated with other diseases.[@b4-copd-12-1233],[@b5-copd-12-1233]

Surgery is essential in many cases of CRC and is associated with considerable mortality (up to 11% at 30 days) and a high rate of complications.[@b6-copd-12-1233],[@b7-copd-12-1233] Many factors are associated with outcomes after different types of surgery, and COPD has been associated with increased short-term mortality. However, few studies of postoperative outcomes in patients with COPD focus on patients with CRC or on postoperative outcomes other than mortality, such as reintervention, complications, or length of stay (LOS).[@b8-copd-12-1233] Recently, Platon et al[@b9-copd-12-1233] found COPD was a strong predictor of intensive care unit (ICU) admission and 30-day mortality after CRC surgery.[@b9-copd-12-1233]

Poorer outcomes after surgery in patients with COPD are related to respiratory failure or other postoperative complications, which can lead to higher short-term mortality. In patients undergoing abdominal surgery, the most common short-term complications include not only infection or other complications involving the site of surgery but also organ failure, including respiratory failure or ventilator problems. In patients with COPD, respiratory complications are probably even more common, adding complexity to immediate postoperative management and increasing the likelihood of worse outcomes.

Despite the prevalence and importance of COPD, few studies have analyzed the overall impact of COPD on postoperative (in-hospital) outcomes or on the use of resources in oncologic surgery in general or CRC surgery in particular. We hypothesized that patients undergoing surgery for CRC with COPD as a comorbidity would consume more resources and have worse in-hospital outcomes than similar patients without COPD. To test this hypothesis, we compared some aspects of the care process and short-term outcomes in two cohorts of patients (with and without COPD) undergoing surgery for CRC in diverse hospitals in Spain.

Methods
=======

Design and patients
-------------------

This prospective multicenter cohort study of patients from 22 hospitals located in nine regions of Spain was done in the framework of the REDISSEC-CARESS/CCR (Results and Health Services Research in Colorectal Cancer) study, which addressed diverse research objectives in hospitals treating CRC in Spain for the national health system.[@b10-copd-12-1233] The hospitals' size and technological resources varied widely. The Clinical Research Ethics Committees of the Parc Taulí Sabadell-University Hospital; Hospital del Mar; Fundació Unio Catalana d'Hospitals; Gipuzkoa Health Area; Basque Country; Hospital Galdakao-Usansolo; Hospital Txagorritxu; La Paz University Hospital; Fundación Alcorcón University Hospital; Hospital Universitario Clínico San Carlos (formerly Clinical Research Ethics Committee of Area 7 -- Hospital Clínico San Carlos); and the Regional Clinical Research Ethics Committee of Andalusia approved the study. All patients provided written informed consent.

We included patients undergoing scheduled or urgent surgery for primary invasive CRC in the period from June 2010 through December 2012, whether the goal of surgery was to excise the tumor or to palliate symptoms.

The REDISSEC-CARESS/CCR study excluded patients with only cancer in situ, those with relapsed tumors, those with cancer not located in the colon or rectum, those who died before surgery, those with inoperable cancer, and those transferred for surgery in another center.

Variables and data collection
-----------------------------

Appropriately trained reviewers used a structured questionnaire and a manual to collect data from clinical records and interviews with surgeons about the following clinical variables: age, categorized as \<80 years or ≥80 years; sex; smoking habit; chronic alcoholism; body mass index (BMI), calculated from the weight and height recorded in the clinical history, with BMI \<18.5 considered low, 18.5--25 normal, and BMI \>25 overweight/obese; baseline comorbidities included in the Charlson Index, with Charlson scores classified in three categories (0, 1--2, ≥3); tumor location (colon or rectum); American Society of Anesthesiologists (ASA) score (I--IV); urgency of the intervention; type of surgery (laparoscopic or open); and staging according to the AJCC.[@b11-copd-12-1233]

COPD (eg, emphysema and chronic bronchitis) was considered present when the diagnosis was mentioned in patients' clinical charts. Asthma or other acute or chronic inflammatory diseases of the airways resulting in bronchospasm alone were not considered COPD. Likewise, diffuse interstitial fibrosis or sarcoidosis was not considered COPD.

We recorded the following process variables: postintervention ICU admission, use of invasive mechanical ventilation, and postintervention antibiotic treatment or blood transfusion.

Outcome variables were reintervention, major complications during the intervention, complications during the hospital stay (as described in Quintana et al[@b10-copd-12-1233]), and the LOS after the intervention grouped into four ranges (1--7 days, 8--15 days, 16--30 days, \>30 days). For the purposes of this study, complications were classified by severity into three mutually exclusive categories (none, minor, major) according to the clinical judgment of the surgeons participating in the study, with major complications classified by type (infectious, hemorrhagic, surgical, vascular, or medical). In-hospital mortality was defined as any death occurring before discharge from hospital, independently of the duration of the hospital LOS.

Data analyses
-------------

A descriptive analysis of all variables was carried out. To compare patients with COPD versus those without COPD, we used chi-square tests or Fisher's exact test for categorical variables. For process and outcome variables, we also estimated crude odds ratios (OR) with 95% confidence intervals (CI). We used logistic regression techniques, incorporating statistically or clinically significant variables in the bivariate analysis to estimate the adjusted risk of death during the hospital stay. To adjust for comorbidities, we took the Charlson scores into account. Thus, in addition to the variable COPD, the final regression model included the other significant variables that enabled the maximum discriminatory capacity of the model estimated by the area under the receiver operating characteristic curve with good calibration according to the Hosmer--Lemeshow test.

To estimate the probability of in-hospital death in function of the presence of COPD, we used Kaplan--Meier survival analysis, in which discharge was considered a censoring event. We compared the survival curves of patients with COPD versus those without COPD by log-rank test. We used Cox regression models to estimate the hazard ratio (HR) for hospital mortality, adjusted for the same factors or variables as in the logistic regression model.

We defined statistical significance as *P*\<0.05, and we used IBM Statistical Package for the Social Sciences (SPSS) Statistics 23 and R statistical package 2.15.3 for the analyses.

Results
=======

We analyzed a total of 2,748 patients with CRC (mean age, 68 years); of these, 472 (17.2%) had COPD. [Table 1](#t1-copd-12-1233){ref-type="table"} compares the sociodemographic and clinical variables in patients with COPD versus those without COPD. The COPD group had higher proportions of men (80.5% vs 60.1%, *P*\<0.001), patients aged ≥80 years (25.8% vs 14.7%, *P*\<0.001), patients with chronic alcoholism (22.1% vs 11%, *P*\<0.001), and patients with smoking habit (18.6% vs 12.2%, *P*\<0.001). Moreover, Charlson scores were higher in patients with COPD because comorbidities were more common. Specifically, the following comorbidities were more common in patients with COPD than in those without COPD: heart failure (20% vs 7.6%, *P*\<0.001), diabetes (26% vs 18%, *P*\<0.001), peripheral vascular disease (10.9% vs 4%, *P*\<0.001), peptic ulcers (11.4% vs 4.8%, *P*\<0.001), and primary malignant tumors other than CRC (11.3% vs 6.7%, *P*\<0.001). The most common comorbidities in patients with COPD were diabetes mellitus (25.8%), moderate to severe heart failure (20.3%), peptic ulcer (11.5%), malignant primary tumors other than CRC (11.3%), and peripheral vascular disease (10.9%).

No differences were observed between patients with COPD and those without COPD in the urgency of the intervention, CRC location, or CRC stage. Laparoscopic surgery was less common in patients with COPD (50.9% vs 59.6%, *P*\<0.001). A greater proportion of patients with COPD were classified under ASA III (58.5% vs 34%, *P*\<0.001) and IV (10% vs 2.7%, *P*\<0.001) risk categories.

[Table 2](#t2-copd-12-1233){ref-type="table"} compares the process and outcome variables in patients with COPD versus those without COPD.

A greater proportion of patients with COPD developed complications during the hospital stay (62.5% in patients with COPD vs 47.5% in those without, *P*\<0.001); likewise, a greater proportion of patients with COPD developed more severe complications (38.3% in patients with COPD vs 26.4% in those without, *P*\<0.001). Major infectious, surgical, vascular, and medical complications were more common in patients with COPD. [Table 3](#t3-copd-12-1233){ref-type="table"} reports the frequencies of specific major complications in patients with COPD and in those without. The infectious complications that were more common in patients with COPD than in those without were pneumonia and other respiratory tract infections, intravenous catheter infections, and septic shock. The main surgical complications that were more common in patients with COPD than in those without were the dehiscence of the surgical wound or anastomosis, evisceration, and vascular damage. The main medical complications that were more common in patients with COPD than in those without were cardiac arrest, heart failure, respiratory failure, and renal failure; the risk of major medical complications was 78%--235% higher in patients with COPD (OR 2.443; 95% CI 1.779--3.355).

The greater incidence of complications in patients with COPD was also associated with greater consumption of resources during the hospital stay, longer LOS, and higher in-hospital mortality ([Table 2](#t2-copd-12-1233){ref-type="table"}). Greater proportions of patients with COPD were admitted to the ICU (31.1% vs 23.4%; OR 1.5), received invasive mechanical ventilation (4.2% vs 2.4%; OR 1.8), and received antibiotics after the intervention (53% vs 44%; OR 1.4). Moreover, a greater proportion of patients with COPD required reintervention (11% vs 7.5%; OR 1.5). However, no differences in hemorrhagic complications or blood transfusions were observed between the two groups.

The overall mean LOS after the intervention was 12.4±11.1 days (median 9, range 1--213). COPD was associated with longer LOS. Only 35% of the patients with COPD spent less than a week in hospital after the intervention compared to 48.5% of those without COPD. There was also a trend in the strength of the association between COPD and longer LOS, being especially strong for LOS \>30 days (OR 2.606; 95% CI 1.715--3.959).

A total of 41 (1.5%) patients died in hospital. The risk of death was higher in patients with COPD (OR 5.252; 95% CI 2.824--9.770); after adjustment for the significant variables (age, sex, tumor location, ASA risk, and reintervention), the OR was 3.514 (95% CI 1.662--7.429) and the HR was 2.480 (95% CI 1.228--5.006).

The survival curves ([Figure 1](#f1-copd-12-1233){ref-type="fig"}) show that death occurred earlier in patients with COPD than in those without (log-rank test 14.458; *P*=0.000). The most common causes of death in patients with COPD were septic shock and medical complications.

Discussion
==========

In this nationwide study of patients undergoing surgery for CRC, we found that COPD was associated with higher rates of postoperative complications, ICU admission, antibiotic treatment, reinterventions, and mortality during hospitalization. Moreover, after adjusting for other factors, COPD remained clearly associated with higher and earlier in-hospital mortality.

Previous nationwide studies in the USA found that even after adjusting for other clinical factors, COPD clearly increases postoperative morbidity and mortality (up to 30 days) and LOS in patients undergoing all types of surgery and in patients undergoing all types of abdominal surgery.[@b8-copd-12-1233],[@b12-copd-12-1233] Our results show that these findings are also valid for the more specific group of patients undergoing surgery for CRC in a nationwide sample in Spain.

The prevalence of COPD in our cohort (17%) is similar to that reported in other settings, although differences in important factors make comparisons among studies difficult. A previous study in our setting reported 19% prevalence of COPD in patients undergoing surgery for rectal cancer;[@b13-copd-12-1233] however, the prevalence of COPD was lower in the aforementioned studies in more general surgical populations: 5% in Gupta et al's cohort and 3.8% in Fields and Divino's cohort. COPD is more common in cancer patients, in part, due to the history of smoking habit. In our study, COPD patients were identified concurrently with data collection. Despite the difficulties inherent in this design, it does not seem that the prevalence of COPD has been underestimated.

The only study published to date that focuses on COPD in CRC interventions reported 13% 30-day mortality in patients with COPD, about 70% higher than in those without COPD; these figures varied with different clinical variables.[@b9-copd-12-1233]

The in-hospital mortality rate in our study was low, but it was four times higher in patients with COPD than in those without, remaining significant after adjusting for sex, age, ASA risk, tumor location, and reintervention. Furthermore, patients with COPD died earlier after the intervention, underlining the importance of optimizing pulmonary function when possible and maintaining closer postoperative surveillance in these patients.

The most common causes of death in patients with COPD are respiratory disease and cardiovascular disease.[@b14-copd-12-1233],[@b15-copd-12-1233] As reported in other studies,[@b16-copd-12-1233]--[@b18-copd-12-1233] the prevalence of heart failure and respiratory insufficiency were higher in patients with COPD than in those without. This clinically important difference could explain the higher rates of ICU admission and invasive mechanical ventilation in COPD patients. On the other hand, our COPD patients also had a higher rate of infectious complications after surgery than patients without COPD, which explains, in part, their higher rate of postoperative antibiotic treatment. Among infectious complications, septic shock, pneumonia, and other respiratory tract infections were especially prevalent.

Interestingly, COPD patients in our study had higher rates of wound or anastomosis dehiscence, and even evisceration, partially explaining their higher rate of reintervention. Platon et al[@b9-copd-12-1233] reported similar findings. The higher rates of these surgical complications in patients with COPD are not surprising: coughing is both a frequent symptom of COPD and a common cause of wound dehiscence; many COPD patients receive oral glucocorticoids that delay wound healing; and many lack good nutritional status essential for wound healing.[@b19-copd-12-1233] All these factors explain the longer LOS in patients with COPD.

Conclusion
==========

In conclusion, to reduce morbidity and mortality in patients with COPD undergoing surgery for CRC, several aspects of perioperative management are important: bronchodilator therapy, postoperative analgesia, and respiratory physiotherapy should be optimized and attention should be given to the usual comorbidities in these patients.
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###### 

Sociodemographic and clinical variables in patients with COPD versus in those without, 2010--2012

  Variable                                                    COPD    *P*-value                 
  ----------------------------------------------------------- ------- ----------- ----- ------- ---------
  Sex                                                                                           \<0.001
   Male                                                       1,368   60.1        380   80.5    
   Female                                                     908     39.9        92    19.5    
  Age (years)                                                                                   \<0.001
   \<80                                                       1,937   85.3        350   74.2    
   ≥80                                                        335     14.7        122   25.8    
  Chronic alcoholism                                                                            \<0.001
   No                                                         1,915   89.0        352   77.9    
   Yes                                                        237     11.0        100   22.1    
  Smoking habit                                                                                 \<0.001
   No                                                         1,980   87.8        376   81.4    
   Yes                                                        275     12.2        86    18.6    
  BMI (kg/m^2^)                                                                                 0.846
   Low                                                        12      0.7         3     0.8     
   Normal                                                     522     30.1        108   28.6    
   Overweight/obesity                                         1,202   69.2        266   70.6    
  **Comorbidities**                                                                             
  Charlson Index                                                                                \<0.001
   0                                                          1,913   84.1        322   68.7    
   1--2                                                       299     13.1        124   26.4    
   ≥3                                                         64      2.8         23    4.9     
  Ischemic heart disease                                                                        0.004
   No                                                         2,166   95.3        431   92.1    
   Yes                                                        106     4.7         37    7.9     
  Heart failure (moderate/severe)                                                               \<0.001
   No                                                         2,104   92.4        376   79.7    
   Yes                                                        172     7.6         96    20.3    
  Peripheral vascular disease                                                                   \<0.001
   No                                                         2,186   96.0        418   89.1    
   Yes                                                        90      4.0         51    10.9    
  Cerebrovascular disease                                                                       0.299
   No                                                         2,175   95.6        443   94.5    
   Yes                                                        101     4.4         26    5.5     
  Dementia                                                                                      0.301
   No                                                         2,258   99.2        463   98.7    
   Yes                                                        18      0.8         6     1.3     
  Peptic ulcer                                                                                  \<0.001
   No                                                         2,165   95.2        415   88.5    
   Yes                                                        110     4.8         54    11.5    
  Connective tissue disease                                                                     1.000
   No                                                         2,267   99.6        467   99.6    
   Yes                                                        9       0.4         2     0.4     
  Liver disease                                                                                 \<0.001
   No                                                         2,226   97.8        443   94.5    
   Yes                                                        50      2.2         26    5.5     
  Diabetes                                                                                      \<0.001
   No                                                         1,866   82.0        348   74.2    
   Yes                                                        410     18.0        121   25.8    
  Renal failure (moderate/severe)                                                               0.079
   No                                                         2,225   97.8        452   96.4    
   Yes                                                        51      2.2         17    3.6     
  Hemiplegia                                                                                    0.305
   No                                                         2,265   99.5        465   99.1    
   Yes                                                        11      0.5         4     0.9     
  Leukemia, lymphoma, or any other tumor (past 5 years)               0.001                     
   No                                                         2,124   93.3        416   88.7    
   Yes                                                        152     6.7         53    11.3    
  Metastatic solid tumor (different from colorectal cancer)           0.238                     
   No                                                         2,256   99.1        468   99.8    
   Yes                                                        20      0.9         1     0.2     
  AIDS                                                                                          --
   No                                                         2,276   100.0       469   100.0   
   Yes                                                        0       0.0         0     0.0     
  ASA score                                                                                     \<0.001
   I--II                                                      1,402   63.4        145   31.5    
   III                                                        751     34.0        269   58.5    
   IV                                                         59      2.7         46    10.0    
  **Tumor and intervention**                                                                    
  Location                                                                                      0.554
   Colon                                                      1,633   71.7        345   73.1    
   Rectum                                                     643     28.3        127   26.9    
  Stage                                                                                         0.193
   I                                                          501     22.1        125   26.7    
   II                                                         798     35.2        156   33.3    
   III                                                        749     33.1        143   30.6    
   IV                                                         216     9.5         44    9.4     
  Urgency of intervention                                                                       0.302
   No                                                         2,197   96.5        451   95.6    
   Yes                                                        79      3.5         21    4.4     
  Type of surgery                                                                               0.001
   Laparoscopic                                               1,342   59.6        237   50.9    
   Open                                                       910     40.4        229   49.1    

**Abbreviations:** BMI, body mass index; ASA, American Society of Anesthesiologists.

###### 

Process and outcome variables in patients with COPD versus in those without, 2010--2012

  Variable                                              COPD    *P*-value   OR (95% CI)                       
  ----------------------------------------------------- ------- ----------- ------------- --------- --------- ----------------------
  **Complications**                                                                                           
  Severity of complications                                                               \<0.001             
   No                                                   1,193   52.4        177           37.5                
   Minor                                                481     21.1        114           24.2                1.597 (1.234--2.068)
   Major                                                602     26.4        181           38.3                2.027 (1.611--2.549)
  Infectious (major)                                                                                \<0.001   
   No                                                   2,021   88.8        388           82.2                
   Yes                                                  255     11.2        84            17.8                1.716 (1.311--2.246)
  Hemorrhagic (major)                                                                               0.286     
   No                                                   2,159   94.9        442           93.6                
   Yes                                                  117     5.1         30            6.4                 1.252 (0.828--1.895)
  Surgical (major)                                                                                  \<0.001   
   No                                                   2,004   88.0        380           80.5                
   Yes                                                  272     12.0        92            19.5                1.784 (1.375--2.315)
  Vascular (major)                                                                                  0.035     
   No                                                   2,166   95.2        438           92.8                
   Yes                                                  110     4.8         34            7.2                 1.529 (1.027--2.276)
  Medical (major)                                                                                   \<0.001   
   No                                                   2,141   94.1        409           86.7                
   Yes                                                  135     5.9         63            13.3                2.443 (1.779--3.355)
  **Use of resources**                                                                                        
  Intensive care unit admission                                             \<0.001                           
   No                                                   1,743   76.6        325           68.9                
   Yes                                                  533     23.4        147           31.1                1.479 (1.190--1.839)
  Invasive mechanical ventilation                                           0.027                             
   No                                                   2,221   97.6        452           95.8                
   Yes                                                  55      2.4         20            4.2                 1.787 (1.061--3.011)
  In-hospital antibiotic treatment (postintervention)                       0.001                             
   No                                                   1,274   56.0        223           47.2                
   Yes                                                  1,002   44.0        249           52.8                1.420 (1.164--1.732)
  Blood transfusion                                                                                 0.444     
   No                                                   1,702   74.8        345           73.1                
   Yes                                                  574     25.2        127           26.9                1.092 (0.872--1.366)
  Reintervention                                                                                    0.010     
   No                                                   2,106   92.5        420           89.0                
   Yes                                                  170     7.5         52            11.0                1.534 (1.105--2.129)
  Postintervention LOS (days)                                               \<0.001                           
   1--7                                                 1,104   48.5        164           34.7                
   8--15                                                799     35.1        194           41.1                1.634 (1.303--2.051)
   16--30                                               278     12.2        78            16.5                1.889 (1.399--2.549)
   \>30                                                 93      4.1         36            7.6                 2.606 (1.715--3.959)
  **In-hospital death**                                                                             \<0.001   
   No                                                   2,256   99.1        451           95.6                
   Yes                                                  20      0.9         21            4.4                 5.252 (2.824--9.770)

**Abbreviations:** LOS, length of stay; OR, odds ratio; 95% CI, 95% confidence interval.

###### 

Major complications in patients with COPD versus in those without COPD

  Type of complication                            COPD    *P*-value                     
  ----------------------------------------------- ------- ----------- ------- --------- ---------
  **Infectious**                                                                        \<0.001
   No                                             2,021   88.8        388     82.2      
   Yes                                            255     11.2        84      17.8      
  Pneumonia                                                                             0.018
   No                                             2,250   98.9        460     97.5      
   Yes                                            26      1.1         12      2.5       
  Catheter infection                                                                    0.006
   No                                             2,235   98.2        454     96.2      
   Yes                                            41      1.8         18      3.8       
  Sepsis                                                                                0.158
   No                                             2,266   99.6        467     98.9      
   Yes                                            10      0.4         5       1.1       
  Septic shock                                                                          0.030
   No                                             2,224   97.7        453     96.0      
   Yes                                            52      2.3         19      4.0       
  Localized intra-abdominal infection (abscess)           0.341                         
   No                                             2,204   96.8        453     96.0      
   Yes                                            72      3.2         19      4.0       
  Peritonitis                                                                           0.036
   No                                             2,212   97.2        450     95.3      
   Yes                                            64      2.8         22      4.7       
  Deep surgical infection                                                     0.705     
   No                                             2,211   97.1        457     96.8      
   Yes                                            65      2.9         15      3.2       
  Respiratory tract infection                                                 0.001     
   No                                             2,266   99.6        462     97.9      
   Yes                                            10      0.4         10      2.1       
  **Hemorrhagic complication**                                                          0.286
   No                                             2,159   94.9        442     93.6      
   Yes                                            117     5.1         30      6.4       
  Bleeding wound                                                                        0.905
   No                                             2,225   97.8        461     97.7      
   Yes                                            51      2.2         11      2.3       
  Internal bleeding of other organs                                           0.074     
   No                                             2,222   97.6        454     96.2      
   Yes                                            54      2.4         18      3.8       
  Hemoperitoneum                                                                        0.309
   No                                             2,255   99.1        465     98.5      
   Yes                                            21      0.9         7       1.5       
  **Surgical complication**                                                             \<0.001
   No                                             2,004   88.0        380     80.5      
   Yes                                            272     12.0        92      19.5      
  Wound leakage                                                                         0.007
   No                                             2,214   97.3        448     94.9      
   Yes                                            62      2.7         24      5.1       
  Anastomotic leakage                                                                   0.022
   No                                             2,193   96.4        444     94.1      
   Yes                                            83      3.6         28      5.9       
  Evisceration                                                                          0.003
   No                                             2,250   98.9        458     97.0      
   Yes                                            26      1.1         14      3.0       
  Necrosis (abdominal wall)                                                   0.390     
   No                                             2,269   99.7        469     99.4      
   Yes                                            7       0.3         3       0.6       
  Enterocutaneous fistula                                                     0.110     
   No                                             2,249   98.8        462     97.9      
   Yes                                            27      1.2         10      2.1       
  Biliary fluid in peritoneum                                                 0.530     
   No                                             2,273   99.9        471     99.8      
   Yes                                            3       0.1         1       0.2       
  Urological injuries                                                                   1.000
   No                                             2,266   99.6        470     99.6      
   Yes                                            10      0.4         2       0.4       
  Vascular injuries                                                                     0.010
   No                                             2,272   99.8        467     98.9      
   Yes                                            4       0.2         5       1.1       
  Neurological injuries                                                                 
   No                                             2,276   100.0       472     100.0     
   Yes                                            0       0.0         0       0.0       
  Other organ laceration                                                      0.099     
   No                                             2,246   98.7        461     97.7      
   Yes                                            30      1.3         11      2.3       
  **Vascular**                                                                          0.035
   No                                             2,166   95.2        438     92.8      
   Yes                                            110     4.8         34      7.2       
  Transient ischemic attack                                                   0.530     
   No                                             2,273   99.9        471     99.8      
   Yes                                            3       0.1         1       0.2       
  Pulmonary embolism                                                          0.038     
   No                                             2,274   99.9        469     99.4      
   Yes                                            2       0.1         3       0.6       
  Angor or acute myocardial infarction                                0.075             
   No                                             2,171   95.4        441     93.4      
   Yes                                            105     4.6         31      6.6       
  **Medical complication**                                                              \<0.001
   No                                             2,141   94.1        409     86.7      
   Yes                                            135     5.9         63      13.3      
  Cardiac arrest                                                                        \<0.001
   No                                             2,273   99.9        465     98.5      
   Yes                                            3       0.1         7       1.5       
  Heart failure                                                                         0.016
   No                                             2,244   98.6        458     97.0      
   Yes                                            32      1.4         14      3.0       
  Kidney failure                                                                        \<0.001
   No                                             2,224   97.7        447     94.7      
   Yes                                            52      2.3         25      5.3       
  Respiratory problems/failure                                                \<0.001   
   No                                             2,215   97.3        438     92.8      
   Yes                                            61      2.7         34      7.2       
  Intestinal obstruction                                                                0.166
   No                                             2,254   99.0        464     98.3      
   Yes                                            22      1.0         8       1.7       
  Multiorgan failure                                                                    0.076
   No                                             2,267   99.6        467     98.9      
   Yes                                            9       0.4         5       1.1       

**Abbreviation:** %Col, column percentage.
